Patents by Inventor Andrew Cragg

Andrew Cragg has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11337714
    Abstract: Devices for restoring blood flow to facilitate lysis of clots and/or enable capture of clots are disclosed. The devices can be configured to be disposed within a lumen of a microcatheter that is inserted within neurovasculature above a carotid siphon to a location of a clot. The devices can include an elongate pusher member and a self-expandable capturing member coupled to a distal end of the elongate pusher member. The capturing member can comprise a generally cylindrical body having an cell structure that is configured to compress the clot against an inner wall of the neurovasculature and capture the clot at least partially on a surface of the generally cylindrical body upon deployment of the capturing member from the microcatheter, thereby restoring blood flow to the neurovasculature downstream of the clot.
    Type: Grant
    Filed: September 5, 2019
    Date of Patent: May 24, 2022
    Assignee: COVIDIEN LP
    Inventors: David Ferrera, Andrew Cragg, John Fulkerson
  • Patent number: 11197977
    Abstract: A catheter has a jacket (10, 11, 5) defining a lumen and a helical support (6). The catheter has a proximal portion (1) and a distal portion (3), the distal portion having for at least some of its length a corrugated outer surface. A transition portion has a flexural stiffness which is less than that of the distal portion and more than that of the proximal portion. The transition portion provides an optimum transition in flexural stiffness by way of features of the jacket including geometry of jacket corrugations (15), or overlapping tubular layers (1073, 1074). The distal end of the distal portion may have an extension of liner material folded over (1072, 1082) to provide a particularly soft tip. In other examples the liner is terminated (763) before the distal tip. The catheter is particularly suited to an aspiration device (1350) with a flow restrictor (1353) and the distal portion distal of the flow restrictor.
    Type: Grant
    Filed: March 13, 2020
    Date of Patent: December 14, 2021
    Assignee: Perfuze Limited
    Inventors: Liam Mullins, Dara Finneran, Alejandro Espinosa, Lisandro Rivera, Robert Farnan, Brett Naglreiter, John Logan, Andrew Cragg
  • Publication number: 20210361910
    Abstract: A catheter has a jacket (10, 11, 5) defining a lumen and a helical support (6). The catheter has a proximal portion (4) and a distal portion (3), the distal portion having for at least some of its length a corrugated outer surface. A transition portion has a flexural stiffness which is less than that of the distal portion and more than that of the proximal portion. The transition portion provides an optimum transition in flexural stiffness by way of features of the jacket including geometry of jacket corrugations (15), or overlapping tubular layers (1073, 1074). The distal end of the distal portion may have an extension of liner material folded over (1072, 1082) to provide a particularly soft tip. In other examples the liner is terminated (763) before the distal tip. The catheter is particularly suited to an aspiration device (1350) with a flow restrictor (1353) and the distal portion distal of the flow restrictor.
    Type: Application
    Filed: August 6, 2021
    Publication date: November 25, 2021
    Applicant: Perfuze Limited
    Inventors: Liam MULLINS, Dara FINNERAN, Alejandro ESPINOSA, Lisandro RIVERA, Robert FARNAN, Brett NAGLREITER, John LOGAN, Andrew CRAGG
  • Publication number: 20200206458
    Abstract: A catheter has a jacket (10, 11, 5) defining a lumen and a helical support (6). The catheter has a proximal portion (1) and a distal portion (3), the distal portion having for at least some of its length a corrugated outer surface. A transition portion has a flexural stiffness which is less than that of the distal portion and more than that of the proximal portion. The transition portion provides an optimum transition in flexural stiffness by way of features of the jacket including geometry of jacket corrugations (15), or overlapping tubular layers (1073, 1074). The distal end of the distal portion may have an extension of liner material folded over (1072, 1082) to provide a particularly soft tip. In other examples the liner is terminated (763) before the distal tip. The catheter is particularly suited to an aspiration device (1350) with a flow restrictor (1353) and the distal portion distal of the flow restrictor.
    Type: Application
    Filed: March 13, 2020
    Publication date: July 2, 2020
    Applicant: Perfuze Limited
    Inventors: Liam MULLINS, Dara Finneran, Alejandro ESPINOSA, Lisandro RIVERA, Robert FARNAN, Brett NAGLREITER, John LOGAN, Andrew CRAGG
  • Publication number: 20190388108
    Abstract: Devices for restoring blood flow to facilitate lysis of clots and/or enable capture of clots are disclosed. The devices can be configured to be disposed within a lumen of a microcatheter that is inserted within neurovasculature above a carotid siphon to a location of a clot. The devices can include an elongate pusher member and a self-expandable capturing member coupled to a distal end of the elongate pusher member. The capturing member can comprise a generally cylindrical body having an cell structure that is configured to compress the clot against an inner wall of the neurovasculature and capture the clot at least partially on a surface of the generally cylindrical body upon deployment of the capturing member from the microcatheter, thereby restoring blood flow to the neurovasculature downstream of the clot.
    Type: Application
    Filed: September 5, 2019
    Publication date: December 26, 2019
    Inventors: David Ferrera, Andrew Cragg, John Fulkerson
  • Patent number: 10413310
    Abstract: Devices for restoring blood flow to facilitate lysis of clots and/or enable capture of clots are disclosed. The devices can be configured to be disposed within a lumen of a microcatheter that is inserted within neurovasculature above a carotid siphon to a location of a clot. The devices can include an elongate pusher member and a self-expandable capturing member coupled to a distal end of the elongate pusher member. The capturing member can comprise a generally cylindrical body having an cell structure that is configured to compress the clot against an inner wall of the neurovasculature and capture the clot at least partially on a surface of the generally cylindrical body upon deployment of the capturing member from the microcatheter, thereby restoring blood flow to the neurovasculature downstream of the clot.
    Type: Grant
    Filed: February 2, 2015
    Date of Patent: September 17, 2019
    Assignee: Covidien LP
    Inventors: David Ferrera, Andrew Cragg, John Fulkerson
  • Patent number: 9320532
    Abstract: Systems, methods, and devices for the treatment of acute ischemic stroke that provide immediate blood flow restoration to a vessel occluded by a clot and, after reestablishing blood flow, address the clot itself. Immediate blood flow restoration advantageously can facilitate natural lysis of the clot and also can reduce or obviate the concern for distal embolization due to fragmentation of the clot. Several embodiments of the invention provide for progressive, or modular, treatment based upon the nature of the clot. For example, the progressive treatment can include immediate restoration of blood flow, in-situ clot management, and/or clot removal depending on the particular circumstances of the treatment. The in-situ clot management can include, for example, lysis, maceration, and/or removal.
    Type: Grant
    Filed: February 2, 2015
    Date of Patent: April 26, 2016
    Assignee: Covidien LP
    Inventors: David Ferrera, Andrew Cragg, John Fulkerson
  • Patent number: 9198687
    Abstract: An acute stroke recanalization system and processes include catheter-based improved reconstrainable or tethered neurological devices which are deliverable through highly constricted and tortuous vessels, crossing the zone associated with subject thrombi/emboli, where deployment impacts, addresses or bridges the embolus, compacting the same into luminal walls which enables perfusion and lysis of the embolus, while the improved neurological medical device itself remains contiguous with the delivery system acting as a filter, basket or stand alone stenting mechanism, depending on the status of the embolus and other therapeutic aspects of the treatment being offered for consideration.
    Type: Grant
    Filed: May 19, 2008
    Date of Patent: December 1, 2015
    Assignee: Covidien LP
    Inventors: John Fulkerson, David A. Ferrera, Andrew Cragg
  • Publication number: 20150209058
    Abstract: Systems, methods, and devices for the treatment of acute ischemic stroke that provide immediate blood flow restoration to a vessel occluded by a clot and, after reestablishing blood flow, address the clot itself. Immediate blood flow restoration advantageously can facilitate natural lysis of the clot and also can reduce or obviate the concern for distal embolization due to fragmentation of the clot. Several embodiments of the invention provide for progressive, or modular, treatment based upon the nature of the clot. For example, the progressive treatment can include immediate restoration of blood flow, in-situ clot management, and/or clot removal depending on the particular circumstances of the treatment. The in-situ clot management can include, for example, lysis, maceration, and/or removal.
    Type: Application
    Filed: February 2, 2015
    Publication date: July 30, 2015
    Inventors: David Ferrera, Andrew Cragg, John Fulkerson
  • Publication number: 20150157346
    Abstract: Devices for restoring blood flow to facilitate lysis of clots and/or enable capture of clots are disclosed. The devices can be configured to be disposed within a lumen of a microcatheter that is inserted within neurovasculature above a carotid siphon to a location of a clot. The devices can include an elongate pusher member and a self-expandable capturing member coupled to a distal end of the elongate pusher member. The capturing member can comprise a generally cylindrical body having an cell structure that is configured to compress the clot against an inner wall of the neurovasculature and capture the clot at least partially on a surface of the generally cylindrical body upon deployment of the capturing member from the microcatheter, thereby restoring blood flow to the neurovasculature downstream of the clot.
    Type: Application
    Filed: February 2, 2015
    Publication date: June 11, 2015
    Inventors: David Ferrera, Andrew Cragg, John Fulkerson
  • Publication number: 20110190797
    Abstract: An acute stroke recanalization system and processes include catheter-based improved reconstrainable or tethered neurological devices which are deliverable through highly constricted and tortuous vessels, crossing the zone associated with subject thrombi/emboli, where deployment impacts, addresses or bridges the embolus, compacting the same into luminal walls which enables perfusion and lysis of the embolus, while the improved neurological medical device itself remains contiguous with the delivery system acting as a filter, basket or stand alone stenting mechanism, depending on the status of the embolus and other therapeutic aspects of the treatment being offered for consideration.
    Type: Application
    Filed: April 12, 2011
    Publication date: August 4, 2011
    Applicant: MINDFRAME, INC.
    Inventors: John Fulkerson, David A. Ferrera, Andrew Cragg
  • Publication number: 20100318097
    Abstract: An acute stroke recanalization system and processes include catheter-based improved reconstrainable or tethered neurological devices which are deliverable through highly constricted and tortuous vessels, crossing the zone associated with subject thrombi/emboli, where deployment impacts, addresses or bridges the embolus, compacting the same into luminal walls which enables perfusion and lysis of the embolus, while the improved neurological medical device itself remains contiguous with the delivery system acting as a filter, basket or stand alone stenting mechanism, depending on the status of the embolus and other therapeutic aspects of the treatment being offered for consideration.
    Type: Application
    Filed: July 13, 2010
    Publication date: December 16, 2010
    Applicant: MINDFRAME, INC.
    Inventors: David A. Ferrera, John Fulkerson, Andrew Cragg
  • Publication number: 20100217187
    Abstract: A microcatheter having an active segment reperfuses occluded blood vessels above the junction of the subclavian artery and common carotid artery. The microcatheter is used to penetrate emboli. Once an embolus is penetrated, the active segment of the microcatheter is activated, causing it to expand radially and thereby open a channel in the embolus. Thus, a channel for restored blood flow is created. The blood's natural lytic action further degraded the embolus in some cases. Therapeutic agents may be administered through the microcatheter to aid in the reperfusion process.
    Type: Application
    Filed: February 23, 2010
    Publication date: August 26, 2010
    Inventors: John FULKERSON, Andrew Cragg, David A. Ferrera
  • Publication number: 20100174309
    Abstract: An acute stroke recanalization systems and processes include catheter-based improved reconstrainable or tethered neurological devices which are deliverable through highly constricted and tortuous vessels, crossing the zone associated with subject thrombi/emboli, where deployment impacts, addresses or bridges the embolus, compacting the same into lumenal walls which enables perfusion and lysis of the embolus, while the improved neurological medical device itself remains contiguous with the delivery system acting as a filter, basket or stand alone alternate medical device, depending on the status of the embolus and other therapeutic aspects of the treatment being offered for consideration.
    Type: Application
    Filed: December 31, 2009
    Publication date: July 8, 2010
    Applicant: MINDFRAME, INC.
    Inventors: JOHN FULKERSON, David A. Ferrera, Andrew Cragg
  • Patent number: 7625352
    Abstract: A depth and puncture control system for a blood vessel hemostasis system includes a blood vessel puncture control tip which, when positioned in the lumen of a blood vessel, can inhibit the flow of blood out of the puncture site. When used together with a pledget delivery cannula and a pledget pusher, the control tip and the delivery catheter can both inhibit blood loss out the puncture site and inhibit the introduction of pledget material and tissue fragments into the blood vessel. The system also includes a handle which releasably connects together the control tip, pusher, and delivery cannula to permit limited longitudinal motion between the control tip and the delivery cannula, and between the pusher and the delivery cannula.
    Type: Grant
    Filed: July 24, 2000
    Date of Patent: December 1, 2009
    Assignee: Sub-Q, Inc.
    Inventors: Mark Ashby, Andrew Cragg, Luis Urquidi, Eduardo Chi-Sing, Eric Lee
  • Publication number: 20090105737
    Abstract: An acute stroke recanalization system and processes include catheter-based improved reconstrainable or tethered neurological devices which are deliverable through highly constricted and tortuous vessels, crossing the zone associated with subject thrombi/emboli, where deployment impacts, addresses or bridges the embolus, compacting the same into luminal walls which enables perfusion and lysis of the embolus, while the improved neurological medical device itself remains contiguous with the delivery system acting as a filter, basket or stand alone stenting mechanism, depending on the status of the embolus and other therapeutic aspects of the treatment being offered for consideration.
    Type: Application
    Filed: May 19, 2008
    Publication date: April 23, 2009
    Applicant: MINDFRAME, INC.
    Inventors: John Fulkerson, David A. Ferrera, Andrew Cragg
  • Publication number: 20080097606
    Abstract: A medical device and methods to relieve joint pain and adapted for knee joint repair, replacement and augmentation. The invention discloses joint lubricant, particularly hyaluronate compositions and methods for treatment of osteoarthritis.
    Type: Application
    Filed: October 15, 2007
    Publication date: April 24, 2008
    Inventors: Andrew Cragg, Richard Greff, George Wallace, Robert Socci, Jr., Jonathan Kagan, Rodlofo Quijano, Hosheng Tu
  • Publication number: 20080097452
    Abstract: Disclosed are surgical tools, tool sets and methods for percutaneously accessing and preparing treatment sites within the spine for subsequent treatment procedures. The treatment site may be an inter-vertebral motion segments in the lumbar and sacral regions of the spine. The tool set may comprise introducer tools and bone dilators for accessing and tapping into a targeted site, such as, for example, the anterior surface of the S1 vertebral body. The tool set may also comprise cutters and extractors for preparing the treatment site for subsequent treatment procedures. The tool set may additionally comprise a bone graft inserter, an exchange system, and/or a temporary distraction tool for further preparing the treatment site for subsequent treatment procedures.
    Type: Application
    Filed: December 10, 2007
    Publication date: April 24, 2008
    Applicant: TranS1 Inc.
    Inventors: Robert Assell, Stephen Ainsworth, Andrew Cragg, Eugene Dickhudt
  • Publication number: 20080091199
    Abstract: Methods and apparatus for forming one or more trans-sacral axial instrumentation/fusion (TASIF) axial bore through vertebral bodies in general alignment with a visualized, anterior or posterior axial instrumentation/fusion line (AAIFL or PAIFL) in a minimally invasive, low trauma, manner and providing a therapy to the spine employing the axial bore. Anterior or posterior starting positions aligned with the AAIFL or PAIFL are accessed through respective anterior and posterior tracts. Curved or relatively straight anterior and curved posterior TASIF axial bores are formed from the anterior and posterior starting positions. The therapies performed through the TASIF axial bores include discoscopy, full and partial discectomy, vertebroplasty, balloon-assisted vertebroplasty, drug delivery, electrical stimulation and various forms of spinal disc cavity augmentation, spinal disc replacement, fusion of spinal motion segments and implantation of radioactive seeds.
    Type: Application
    Filed: December 13, 2007
    Publication date: April 17, 2008
    Applicant: TRANS1 INC.
    Inventor: Andrew Cragg
  • Publication number: 20080071282
    Abstract: Disclosed are surgical tools, tool sets and methods for percutaneously accessing and preparing treatment sites within the spine for subsequent treatment procedures. The treatment site may be an inter-vertebral motion segments in the lumbar and sacral regions of the spine. The tool set may comprise introducer tools and bone dilators for accessing and tapping into a targeted site, such as, for example, the anterior surface of the S1 vertebral body. The tool set may also comprise cutters and extractors for preparing the treatment site for subsequent treatment procedures. The tool set may additionally comprise a bone graft inserter, an exchange system, and/or a temporary distraction tool for further preparing the treatment site for subsequent treatment procedures.
    Type: Application
    Filed: November 19, 2007
    Publication date: March 20, 2008
    Applicant: TRANS1 INC.
    Inventors: Robert Assell, Steven Ainsworth, Andrew Cragg, Eugene Dickhudt